Unlicensed Botox and Filler Injections: The Criminal Exposure Behind the New Connecticut Dentist Scope Law

If you own a med spa, inject for one, or supervise the people who do, the line between a lawful cosmetic procedure and a crime is getting sharper. Connecticut just drew part of that line in statute. On May 14, 2026, the state enacted Public Act No. 26-13. Section 34 lets trained dentists administer botulinum toxin and dermal fillers starting October 1, 2026, but only inside narrow facial regions, with hands-on training, liability coverage, and no delegation to assistants. That same month, a Texas dental assistant was charged with performing lip filler injections without a license. Read those two items together and the direction is clear. States are defining exactly who may inject, with what, and where. Step outside those lines and you are not looking at a licensing fine. You are looking at a criminal case.

Connecticut Public Act No. 26-13 defines exactly who may inject, where, and under what conditions. That precision creates the legal boundary that turns an unlawful injection into a criminal charge.

Key Takeaways

• Connecticut Public Act No. 26-13, Section 34, lets trained dentists inject botulinum toxin and fillers only within defined facial regions and bars delegation to dental assistants or hygienists.
• Injecting without the right license is prosecuted as unauthorized practice of medicine. In Florida that runs through Fla. Stat. § 458.327, a third-degree felony, escalating to a first-degree felony when it causes serious injury.
• Federal exposure attaches when injectables are misbranded or unapproved drugs under 21 U.S.C. §§ 331 and 333, or when billing crosses into Medicare under 18 U.S.C. § 1347.
• South Florida is one of the most aggressive federal health care enforcement districts in the country, and med spa and injectable cases are now part of that docket.
• These cases are controlled before charges are filed. Pre-indictment defense, at the target-letter and grand-jury stage, is where the outcome is decided.

What Connecticut Actually Did

Public Act No. 26-13 grew out of Substitute House Bill No. 5514 and was signed on May 14, 2026. Section 34, the cosmetic injection provision, takes effect October 1, 2026.

It permits a Connecticut dentist to administer cosmetic facial injections, including botulinum toxin and dermal fillers, only if the dentist completes in-person, hands-on training through an accredited continuing education program and carries professional liability insurance covering the procedure.

The grant is narrow on purpose. Dentists may treat the lateral canthal region, including lateral canthal rhytids, and may use malar, zygomatic, or midface dermal filler when the primary target is the cheek or midface and the injection stays below the infraorbital rim. The statute then walls off the rest of the face. The tear trough, infraorbital hollow, eyelids, medial canthal region, forehead, glabella, and eyebrows are off limits. Dentists may not delegate any of it to dental assistants or hygienists.

Connecticut is not an outlier. Virginia Board of Dentistry rules on cosmetic botulinum toxin training for dentists took effect in May 2026. The pattern matters more than any single state. Legislatures and boards are writing down, with precision, who is allowed to put a needle in a patient's face.

Connecticut's statute lists exactly which facial regions are permitted and which are barred. That specificity is what transforms an unlawful injection from a regulatory matter into a prosecutable crime.

Where the Criminal Risk Lives

A permissive scope law sounds like good news, and for a properly trained, properly insured dentist it is. The risk is everyone operating outside the lines the statute just made explicit.

When a state spells out the exact conditions for a lawful injection, it also spells out what an unlawful one looks like. That is the part med spa operators tend to miss.

The Texas case in the same news cycle is the tell. A dental assistant was accused of injecting lip filler without medical licensure inside a salon suite. That is not a paperwork problem. Across the country, performing medical procedures without the required license is charged as the unauthorized practice of medicine. In Florida it is prosecuted under Fla. Stat. § 458.327, a third-degree felony, and it escalates to a first-degree felony when the unlicensed practice causes serious bodily injury. Supervising physicians and owners who let it happen face their own exposure under the supervision and delegation rules in Fla. Stat. § 458.331.

Most med spa injectors are not dentists or physicians. They are nurses, advanced practice providers, or unlicensed staff working under a supervision arrangement that may exist on paper and nowhere else. When the supervising provider never performs a good faith exam, never sees the patient, and signs orders for a clinic in another state, the arrangement is exactly what investigators look for.

Federal investigators work from billing records, supervision agreements, and client intake logs. A supervision arrangement that exists only on paper does not survive that scrutiny.

When a Scope Problem Becomes a Federal Case

State licensing is only the first layer. The federal hook is the drug and the money.

Compounded and imported injectables, peptides marked research use only, and GLP-1 products sourced outside the approved supply chain are treated as misbranded or unapproved drugs. Introducing them into interstate commerce is a prohibited act under 21 U.S.C. § 331, and the penalties, including felony exposure for intent to defraud or mislead, sit in 21 U.S.C. § 333.

Add billing and the exposure multiplies. If any of the work touches Medicare, Medicaid, or a private plan, prosecutors reach for health care fraud under 18 U.S.C. § 1347 and false statements in health care under 18 U.S.C. § 1035. Referral and supervision payments that do not hold up draw the federal Anti-Kickback Statute, 42 U.S.C. § 1320a-7b. Two or more people coordinating any of it supports a conspiracy count under 18 U.S.C. § 1349, which lets the government charge the owner who never touched a syringe.

Telehealth that crosses state lines is what turns a local clinic into a federal venue. Sentencing exposure under these statutes reaches ten years per count, before fraud-loss enhancements and parallel civil liability. The government does not need a bad medical outcome to bring the case. It needs an unapproved drug, an interstate shipment, a billing record, or a supervision relationship that does not survive scrutiny.

The Mistakes That Turn an Inquiry Into an Indictment

Talking to investigators without counsel. An FDA, HHS-OIG, or FBI agent at the front desk is not there for a friendly chat. Statements made in that moment become the spine of the case.

Producing documents without a strategy. A records request answered without a litigation hold and a privilege review can hand the government its theory.

Assuming silence means safety. No charge yet does not mean no investigation. Grand jury work happens quietly for months.

Waiting for the indictment to hire a lawyer. By then the charging decision is largely made, and the leverage that existed at the target-letter stage is gone.

A Florida criminal complaint for unauthorized practice of medicine sits beside a Connecticut scope-law printout. State licensing violations and federal criminal charges can run in parallel from the same set of facts.

Strategic Defense, and Why Timing Decides It

Med spa and injectable cases are won in the pre-indictment window. Early federal investigation defense means getting in front of the prosecutor before the charging decision hardens, presenting the facts that complicate the government's theory, and controlling the narrative while it can still be shaped.

A target letter is an invitation to do exactly that, not a reason to panic.

There is real decision-making to do. Whether to cooperate or litigate, how to handle a supervising provider whose interests may diverge from the clinic owner's, how to position for sentencing if charges proceed. Each of those calls is easier and cheaper to make early. The window to influence the outcome closes when the indictment is returned.

Common Questions

Facing a Med Spa or Injectable Investigation in Florida?

If you own or operate a med spa, inject professionally, or supervise injectors, and you have received a target letter, a grand jury subpoena, or an unannounced agency visit, the time to act is now, before any charging decision is made. AMC Defense Law handles federal and state criminal matters involving health care, compounded and peptide drug enforcement, and white-collar exposure, in Florida and nationwide. Consultations are confidential.

Aaron M. Cohen represents med spa owners, injectors, and practice supervisors in federal and state investigations in South Florida and nationwide.

This article is for informational purposes only and does not constitute legal advice. Reading this article does not create an attorney-client relationship. If you are under investigation or believe you may be a target of a federal or state health care investigation, consult a qualified federal criminal defense attorney immediately.